Skip to main content
Cangrelor 50 mg/1 injection, powder, lyophilized, for solution by Gland Pharma Limited
Cangrelor, 50 mg/1, injection, powder, lyophilized, for solution Drug class: P2Y12 Platelet Inhibitor. Available on prescription only. Listed by Gland Pharma Limited.
Prescription only Generic

Cangrelor

Listed by Gland Pharma Limited

Strength
50 mg/1
Form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Class
P2Y12 Platelet Inhibitor

What it contains

  • Cangrelor 50 mg/1

FDA record

Dosage form Injection, Powder, Lyophilized, For Solution
Route Intravenous
Drug class P2Y12 Platelet Inhibitor
Approval route ANDA — approved generic
NDC code 68083-412
FDA application ANDA213551
RxNorm concept 1656056
Package sizes listed 1
Marketed since August 2025

Other products containing Cangrelor

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

KENGREAL

cangrelor

Strength
50 mg/1
Form
Injection, Powder, Lyophilized, For Solution
Class
P2Y12 Platelet Inhibitor
Rx only

Chiesi USA, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.